Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor

J Immunol. 1996 Sep 1;157(5):1935-43.

Abstract

To find out how physiologically secreted IFN-gamma controls either the proliferation or the apoptosis of human T lymphocytes, the kinetics of expression of the alpha- and beta-chains of its receptor (IFN-gamma R) were sequentially followed on T lymphocytes first activated with PHA and then cultured in the presence of IL-2, and related to the kinetics of expression of Fas, Bcl-2, and IL-2R p55 chain. Both IFN-gamma R chains were poorly expressed on the membrane of resting T lymphocytes. Following their stimulation with PHA, IFN-gamma R alpha but not IFN gamma R beta-chain up-modulated before T lymphocyte entry into the S phase, and then IFN-gamma R alpha down-modulated when they passed through the S and G2/M. The ensuing proliferative response was inhibited by an anti-IFN-gamma R alpha mAb that impeded the binding of IFN-gamma. When PHA-activated T lymphoblasts were cultured for 16 days with IL-2, IFN-gamma R alpha expression increased, whereas that of the beta-chain remained barely detectable. Fas and Bcl-2 were both highly expressed. When these T lymphoblasts were restimulated by PHA, OKT3, or Staphylococcus enterotoxin beta-pokeweed mitogen, both chains up-modulated and most cells underwent apoptosis in a way apparently independent of Bcl-2, but not of Fas. This apoptosis, too, was prevented by the anti-IFN-gamma R alpha mAb. Physiologically secreted IFN-gamma is thus involved in the activation of resting T lymphocytes and in the apoptosis of reactivated lymphoblasts. However, high expression of IFN-gamma R beta took place when IFN-gamma induced apoptosis, but not when it induced proliferation. In conclusion, a correlation exists between differential expression of the IFN-gamma R beta-chain and the delivery by IFN-gamma of proliferative or apoptotic signals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antigens, CD / biosynthesis*
  • Antigens, CD / chemistry
  • Apoptosis / drug effects*
  • Enterotoxins / pharmacology
  • Humans
  • Interferon gamma Receptor
  • Interferon-gamma / metabolism*
  • Interferon-gamma / pharmacology*
  • Interleukin-2 / pharmacology
  • Kinetics
  • Lymphocyte Activation / drug effects*
  • Phytohemagglutinins / pharmacology
  • Pokeweed Mitogens / pharmacology
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Receptors, Interferon / biosynthesis*
  • Receptors, Interferon / chemistry
  • Receptors, Interleukin-2 / biosynthesis
  • Staphylococcus aureus / immunology
  • Superantigens / immunology
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / metabolism*
  • fas Receptor / biosynthesis

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Enterotoxins
  • Interleukin-2
  • Phytohemagglutinins
  • Pokeweed Mitogens
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, Interferon
  • Receptors, Interleukin-2
  • Superantigens
  • fas Receptor
  • enterotoxin B, staphylococcal
  • Interferon-gamma